Table 4.
PFS and OS in Treatment Groups | ETS | DoR | ||||
---|---|---|---|---|---|---|
≥20% | <20% | p-Value | ≥Median | <Median | p-Value | |
median PFS (months) | ||||||
FOLFOXIRI | 9.2 | 4.5 | <0.001 | 9.2 | 6.7 | <0.001 |
GemNab | 7.3 | 4.9 | 0.209 | 7.5 | 6.4 | 0.093 |
median OS (months) | ||||||
FOLFOXIRI | 17.5 | 9.6 | <0.001 | 19.5 | 11.5 | 0.005 |
GemNab | 10.6 | 10 | 0.853 | 10.9 | 10.6 | 0.818 |